In conclusion, we showed that CD133+CD44+CD54+ subpopulation of CTCs has a prognostic value in CRC with liver metastasis, and has a significant effect on the survival of CRC patients who did not undergo surgical treatment for metastasis. The gene discussed is ICAM1; the disease is colorectal carcinoma.